Incyte Reports 2024 Fourth Quarter and Year-End Financial Results, Provides 2025 Financial ...
Incyte (Nasdaq:INCY) today announced financial results for the fourth quarter and full year ended December 31, 2024 and provided full year 2025 financial guidance. "2024 ...
Kura, Kyowa Kirin announce KOMET-001 results, FDA feedback for trial designs
Kura Oncology (KURA) and Kyowa Kirin announced topline results from KOMET-001, the Phase 2 registration-directed trial of ziftomenib, a highly ...